1European Pharmacopoeia Secretariat. European pharmacopoeia[M].3rd ed, Stras bourg: European department for the quality of medicines within the council of europe,1997,1516 -1518.
2Planos R,Qner JC. Boix J,et al.Aprospective randomized trial comparing somatostatin and sclerotherapy in thetreatment of acute variceal bleeding[].Hepatology.1994
3Nevens F,Sprengers D,Fevery J.Theeffect of different doses of a bolus in- jection of somatostatin combined witha slow infusion on transmutal oesoph-ageal variceal pressure in patients withcirrhosis[].Journal of Hepatology.1994
4Saari A,Klvilaakso E,Inberg M,et al.Comparison of somatostatill and vaso-pressin in blceding esophageal varices[].The American journal of Gastroenterology.1990
10Goke R, Linn T, Schmidt H, etal. Exendin-4 is a high potency agonist and truncated exendin-(9 - 39)- amide an antagonist at the glucagon-like peptide 1 -(7- 36)- amide receptor of insulin-secreting beta-cells[J]. J Biol Chem, 1993, 268- 19650.
